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ABSTRACT  
 
To identify novel cell ageing markers in order to gain insight into ageing mechanisms, we 
adopted membrane enrichment and comparison of the CD4+ T cell membrane proteome (purified 
by cell surface labelling using Sulfo-NHS-SS-Biotin reagent) between healthy young (n=9, 20-
25y) and older (n=10; 50-70y) male adults. Following two-dimensional gel electrophoresis 
(2DE) to separate  pooled  membrane proteins  in triplicates, the identity of protein spots with 
age-dependent differences (p<0.05 and >1.4 fold difference) was determined using liquid 
chromatography-mass spectrometry (LC-MS/MS).  Seventeen protein spot density differences 
(ten increased and seven decreased in the older adult group) were observed between young and 
older adults. From spot intensity analysis, CD4+ T cell surface α-enolase was decreased in 
expression by 1.5 fold in the older age group; this was verified by flow cytometry (n=22) and 
qPCR with significantly lower expression of cellular α-enolase mRNA and protein compared to 
young adult CD4+ T cells (p<0.05). In an independent age-matched case-control study, lower 
CD4+ T cell surface α-enolase expression was observed in age-matched patients with 
cardiovascular disease (p<0.05). An immune-modulatory role has been proposed for surface α-
enolase and our findings of decreased expression suggest that deficits in surface α-enolase merit 
investigation in the context of immune dysfunction during ageing and vascular disease.   
 
Keywords: enolase, CD4+T cell, plasma membrane proteomics, 2D gel electrophoresis, 
phenotype 
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1. INTRODUCTION 
Biological ageing is a complex process influenced by genetic and environmental factors that 
varies in rate from person to person; chronological age is considered to be a poor indicator of the 
rate of biological ageing (1). While the life spans of identical twins are significantly more similar 
than those of non-identical twins, genetic factors are only estimated to account for between a 
quarter and a third of life span (2). Environmental factors including healthy diet and increased 
levels of physical activity have also been linked to longer life expectancy (3,4).  Biomarkers 
represent an attractive measure of biological ageing and potentially may improve our 
understanding of underlying ageing processes and age-related disease (5). Recent studies suggest 
that cell surface receptors may also be modified post-translationally, undergo changes in 
trafficking or level of expression (6-9). However, to date the cell surface proteome has not been 
investigated systematically for age-dependent biomarkers.  
 
CD4+ T cells are required for effective acquired immunity, and a decline in their function is 
thought to contribute to reduced efficacy of response to infection, vaccination, an increase in 
autoimmunity and cardiovascular disease typically seen with ageing (10-14). This may in part be 
due to the age-related decrease in naïve and increase in antigen experienced CD4+ T cells 
(15,16). Given the observed age-related changes to CD4+ T cell function and the importance of 
cell surface receptor expression and binding for activation, the CD4+ T cell plasma membrane 
proteome may be an important source of biomarkers of ageing.  
 
2DE provides a non-hypothesis driven proteomic approach for biomarker identification, which 
separates all protein isoforms within a sample at a given time point. The technique has been 
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successfully applied to simple experiments undertaken in cell lines and to more complex tissue 
and biological fluids for the purpose of biomarker discovery (17). In the majority of such 
proteomic studies, membrane proteins are often under represented due to their relatively low 
abundance, large size and hydrophobic properties (18). Pre-enrichment of sample with plasma 
membrane proteins prior to separation by 2DE, is one strategy which has been used to improve 
membrane protein representation for proteomic studies (19-21). In this work, we describe a 
membrane purification method which involves labelling of primary amine groups present on 
lysine residues of CD4+ T cell surface membrane proteins with Sulfo-NHS-SS-Biotin reagent 
and subsequent 2DE coupled with LC-MS/MS to identify age-related differences in the CD4+ T 
cell membrane proteome. To our knowledge this represents the first non-hypothesis driven 
approach to study age-related protein expression differences on the cell surface of CD4+ T cells.  
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2. MATERIALS AND METHODS 
 
2.1 Participants 
Young male adults (18-35 years old) and older male adults (50-70 years old) were recruited for 
this study. Several physiological changes are reported from the age of 50 years, around the age of 
menopause for women; it has been proposed that health is preserved evolutionarily to this age to 
allow successful reproduction (2). To avoid oestrogenic hormonal variability alone influencing 
cell surface markers, T cells from males only were analysed. These volunteers were healthy, 
non-smokers and were not taking any disease modifying or anti-inflammatory medication or 
nutritional supplements. Participants provided informed written consent and ethical approval was 
obtained from the Aston University Ethics Committee.  
 
2.2 Blood measurements and processing 
After an overnight fast, 40 mL whole blood was drawn from the antecubital vein of each 
participant and collected into EDTA coated tubes (Greiner Bio-One Ltd, UK) between 8:00 and 
10:30 am.  Anthropometric measurements were recorded and biochemical indices (glucose, total 
cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides) were measured by 
pipetting 30 µL whole blood onto  Reflotron strips (Roche Diagnostics, Indianapolis, USA) then 
determined using a Reflotron blood analyser (Boehringer Mannheim GmbH, Germany). Low 
density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation (22). 
Peripheral blood mononuclear cells (PBMC) were isolated immediately using density gradient 
centrifugation as previously described (23). Briefly, whole blood (20 mL) was mixed 1:1 with 
PBS supplemented with 0.1% w/v BSA, layered onto Lymphoprep (11 mL, Axis-Shield, UK) 
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and centrifuged at 160 x g for 15 minutes. Plasma (5-10 mL) was removed and the preparation 
centrifuged for a further 20 minutes at 350 x g. PBMC (1-2 x 107) were pipetted into a clean 
centrifuge tube (Corning, UK) and washed twice with PBS with 0.1% w/v BSA to remove 
residual Lymphoprep. CD4+ T cells were isolated from PBMC using a negative isolation kit 
(Life Technologies, UK) yielding 5-7 x 106 cells. For analysis of gene expression, mRNA was 
harvested from CD4+ T cells using Trizol® reagent (Invitrogen, Carlsbad, CA). For the purpose 
of flow cytometry for cell surface antigens, whole blood (50µL) was fixed by addition of 500µL 
OptiLyse C (Beckman Coulter) for 2 hours and then stored at -80°C prior to analysis. To 
determine total intra- and extra-cellular protein expression, fixed whole blood was incubated 
with 0.5% saponin in PBS, treated for 10 minutes prior to staining with appropriate antibodies.    
 
2.3 Membrane protein preparation 
Primary human CD4+ T cells (5 x 106 cells) were washed three times in ice cold PBS (1mL; pH 
8) and cell surface proteins labelled with 0.5 mg/mL biotin (Sulfo-NHS-SS-Biotin, Thermo 
Scientific, UK) for 20 minutes at 4 ºC on a rotary mixer. Cells were washed twice with glycine 
(10 mM) to quench the biotinylation reaction and washed once with PBS (pH 8). Cells were 
lysed on ice for 30 minutes in MNE (25mM MES (pH 6.5), 150mM NaCl, 2mM EDTA) lysis 
buffer supplemented with 1mM sodium orthovanadate, 1% v/v Triton X-100 and 0.1% v/v 
protease inhibitor cocktail (Sigma Aldrich, UK), genomic DNA was sheared using a 21 G needle 
(Terumo, UK) and centrifuged at 2,000 xg for 5 minutes to obtain a post-nuclear supernatant 
(PNS). The PNS (1mL) was incubated for 30 minutes at room temperature with 200 µL of pre 
washed Magnabind Streptavidin (SA) beads (Thermo Scientific, UK), an unbound fraction was 
collected and beads were washed twice in MNE lysis buffer and twice in PBS (pH 8). Cell 
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surface proteins were eluted into extraction buffer (8M urea, 2M thiourea, 2% w/v CHAPS, 1% 
v/v DeStreak reagent (GE Healthcare, Amersham, UK) and 0.2% v/v Bio-Lytes (Bio-Rad)) for 
30 minutes at room temperature. PNS, unbound and elution fractions were stored at -80 ºC for 
SDS-PAGE analysis and western blotting. The yield of CD4+ T cell membrane proteins eluted 
ranged from 8-20µg for the 19 subjects studied. 
 
2.4 Confocal microscopy 
Primary CD4+ T cells were biotinylated as described above or left unlabelled and prepared as 
described by Peirce et al. (19). Cells were washed three times with PBS and allowed to adhere to 
poly-L-lysine microscope slides (VWR, UK) for 20 minutes. Adherent CD4+ T cells were 
washed with PBS, fixed for 15 minutes with 1% v/v formaldehyde, 1% w/v BSA in PBS at room 
temperature, rinsed in PBS and either permeabilised with 0.1% v/v Triton X-100 in PBS or 
incubated with PBS for 30 minutes at 4 ºC. Cells were rinsed in PBS, blocked with 1% w/v BSA 
in PBS for 30 minutes at 4ºC and incubated with a 1:1000 dilution of 2mg/mL  SA-Alexa Fluor® 
488 (Life Technologies, UK) for 30 minutes at 4 ºC. Cells were rinsed in PBS and visualized 
using confocal microscopy (Leica, UK). 
 
2.5 2DE, gel staining and image analysis 
Samples were prepared using a 2DE clean-up kit (GE Healthcare, UK) following the 
manufacturer’s instructions. Protein pellets were solubilised overnight at 20ºC in solubilisation 
buffer (8M urea, 2M thiourea, 4% w/v CHAPS) with gentle agitation. Urea/thiourea solutions 
were deionised before use by incubation with a 1% w/v Amberlite mixed bed resin (GE 
Healthcare, UK) for 10 minutes and then filtered. Protein concentration was determined by 
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Bradford assay (Sigma, UK). Purified membrane proteins (8µg) from each of the young donors 
(n=10) and older donors (n=9) were pooled to generate a “young” and “older” adult T cell 
membrane protein pool respectively. To examine differences in protein expression, 2DE was 
undertaken independently on pooled young and older adult membrane proteins, which were run 
in either triplicate (older) or quadruplicate (younger) i.e. three or four repeat 2DE analysis was 
undertaken of the same pool. For 2DE gels, 17-cm ReadyStrip IPG strips (pH 3–10 non-linear) 
were loaded with 15 µg total protein from the appropriate pool of membrane proteins. IPG 
ReadyStrips were rehydrated for 18 hours in the presence of proteins in a volume of 300 µL 
rehydration solution (8M urea, 2M thiourea, 2% w/v CHAPS, 1% v/v DeStreak Reagent, 0.2% 
v/v Bio-Lytes). IEF was performed with a PROTEAN i12 IEF apparatus (Bio-Rad) at 150 V for 
11 h, followed by stepwise application of 1000 and 10000V for a total of 25,000 Vh. After IEF 
ReadyStrip IPG strips were incubated for 15 minutes in equilibration buffer (6M urea, 2% w/v 
SDS, 30% v/v glycerol, 1% w/v DTT, 50mM Tris-HCl, pH 8.6)  and a further 15 minutes in 
equilibration buffer with 4.7% w/v iodoacetamide, applied to 8 –16% gradient SDS-PAGE gels 
(Jules. Inc, USA) and sealed with 1% w/v agarose (Sigma Aldrich, UK). Electrophoresis was 
undertaken using a PROTEAN II multi-cell (Bio-Rad) with electrophoresis buffer (25 mM Tris, 
pH 8.3, 192 mM glycine, and 0.2% w/v SDS) and a current of 40 µA was applied to each gel for 
5 hours or until the gel front had migrated fully. Gels were electrophoresed in parallel and were 
imaged using a PharosFX fluorescent scanner (Bio-Rad). Gels were fixed in 10% v/v acetic acid 
and 40% v/v ethanol for 24 hours and stained with Flamingo fluorescent stain for 8 hours and 
scanned using PharosFX scanner (Bio-Rad). Spot matching and data analysis was performed 
using Progenesis SameSpots software (Nonlinear Dynamics Limited, Newcastle upon Tyne, 
UK). Reproducibility for spot identification between gels was CV<10%. Fold-differences (≥ 1.4 
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fold) in the intensity of spots within triplicate gels were defines as significantly different between 
pooled samples of younger and older male adult groups when p< 0.05, analysed by ANOVA.  
 
2.6 LC-MS/MS 
Protein spots were prepared for protein identification using in gel digestion with trypsin (24). 
Flamingo fluorescence-stained spots were excised, divided into ~2 mm3 cubes and destained with 
acetonitrile followed by 100 mM ammonium bicarbonate. This cycle was repeated until gel 
pieces were destained. Gel pieces were dried (vacuum centrifugation; 5 min) and rehydrated in 
10 mM DTT and 100 mM ammonium bicarbonate and reduced at 60°C for 15 min. The liquid 
was removed and replaced with 50mM iodoacetamide and 100mM ammonium bicarbonate. Gel 
pieces were incubated at room temperature in the dark for 45 min and then washed with 100mM 
ammonium bicarbonate. After drying the gel (vacuum centrifugation; 5 min) 0.3 µg trypsin gold 
(Promega, WI, USA) was added and shaken at room temperature for 30 min, before dilution with 
100 mM ammonium bicarbonate. Hydrolysis was allowed to occur overnight (~16 h) at 37 °C. 
Peptides were extracted with the initial solution of 2% acetonitrile and 0.1% formic acid in water 
was added and shaken for 30 minutes. Supernatant was removed to a clean plate. A second 
peptide extraction was performed using 40% acetonitrile and 0.1% formic acid in water, shaken 
for 30 minutes at room temperature. The supernatant was removed, pooled with the previous 
extracted peptides and dried in an evaporator. The samples were re-suspended in 0.1% formic 
acid in water. 
 
UltiMate® 3000 HPLC series (Dionex, Sunnyvale, CA USA) was used for peptide concentration 
and separation. Samples were separated in Nano Series™ Standard Columns 75 µm i.d. x 15 cm, 
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packed with C18 PepMap100, 3 µm, 100Å (Dionex, Sunnyvale, CA USA). The gradient used 
was from 3.2% to 44% solvent B (0.1% formic acid in acetonitrile) for 30 min. Peptides were 
eluted directly (~ 350 nL min-1) via a  Triversa  Nanomate  nanospray source (Advion 
Biosciences, NY) into a LTQ Orbitrap Velos ETD mass spectrometer (ThermoFisher Scientific, 
Germany). The data-dependent scanning acquisition was controlled by Xcalibur 2.1 software. 
The mass spectrometer alternated between a full FT-MS scan (m/z 380 – 1600) and subsequent 
collision-induced dissociation MS/MS scans of the 7 most abundant ions. Survey scans were 
acquired in the Orbitrap with a resolution of 60 000 at m/z 400 and automatic gain control 1x106. 
Precursor ions were isolated and subjected to collision induced dissociation in the linear ion trap 
with automatic gain control 1x105. Collision activation for the experiment was performed in the 
linear trap using helium gas at normalized collision energy to precursor m/z of 35% and 
activation Q 0.25. The width of the precursor isolation window was 2 m/z and only multiply-
charged precursor ions were selected for MS/MS. 
 
The MS and MS/MS scans were searched against NCBI database using the Mascot algorithm 
(Matrix Sciences). Variable modifications were deamidation (N and Q), oxidation (M), 
carboxyamidomethylation (C) and protein linker (K). The precursor mass tolerance was 10 ppm 
and the MS/MS mass tolerance was 0.8Da. Two missed cleavage was allowed and were accepted 
as a real hit protein with at least two high confidence peptides.  
 
2.7 Western blotting analysis 
Proteins (5 µg) were separated by SDS-PAGE using 10 % polyacrylamide gels and transferred to 
Hybond-P membrane (GE Healthcare, UK) as previously described (24). Membranes were 
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blocked for one hour at room temperature, or overnight at 4ºC with either 3% w/v BSA (Sigma 
Aldrich, UK) or 5% w/v non-fat milk and incubated with rabbit polyclonal anti-cluster of 
differentiation 3 (CD3; 1: 2000, ab5690, AbCam, Cambridge, UK) and mouse monoclonal anti-
lactate dehydrogenase (LDH) (1: 1000; sc-133123, Santa Cruz Biotechnology, USA) primary 
antibodies, and subsequently with peroxidase conjugated goat anti-rabbit (1: 5000; A6154, 
Sigma Aldrich, UK) and goat anti-mouse (1: 20000; A0168, Sigma Aldrich, UK) secondary 
antibodies respectively. Antibody incubations were either for 2 hours at room temperature or 
overnight at 4ºC. After incubation steps membranes were washed three times for 10 minutes in 
TBS with Tween 20 (0.05%). Bands were visualized using enhanced chemiluminescent detection 
(GE Healthcare, UK).  
 
2.8 Flow cytometry analysis 
Peripheral blood leukocytes were washed four times in cold wash buffer (PBS supplemented 
with 1% w/v BSA) and left on ice in blocking buffer (0.3M glycine, 1% w/v BSA and 10% w/v 
goat serum (PAA) in PBS) for 30 minutes. Following four washes in cold wash buffer, cells were 
incubated with mouse monoclonal anti-α-enolase (ab54979) or IgG1 isotype control (ab91353) 
on ice for 30 minutes. After a further four washes, cells were incubated with goat polyclonal to 
mouse IgG1 conjugated FITC (ab97239) on ice for 30 minutes, washed four more times and then 
incubated with mouse monoclonal CD4 conjugated phycoerythrin (PE; ab1155) or mouse IgG2a 
conjugated PE isotype (ab91363) on ice for 30 minutes.  Finally, cells were washed four times in 
cold buffer and analysed in duplicate on a Cytomics FC 500 flow cytometer (Beckman Coulter, 
Wycombe, UK). We prepared a pooled leukocyte preparation from multiple donors to act as a 
single internal quality control (QC). This QC was fixed in Optilyse C, stored frozen in aliquots 
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and a new aliquot was labelled with antibodies freshly each analysis day. We analysed 
leukocytes in batches of 10 in the following order; first from an older in duplicate (1,2), followed 
by younger leukocytes in duplicate (3,4), then repeated this on other older and younger cells (5-
8) before analysing the pooled QC leukocytes (9-10). If the variance between duplicates or QC 
batches was greater than 10%, samples were re-analysed.  Positive staining for each sample was 
defined as fluorescence with no more than 0.5% overlap into the respective isotype negative 
control. Viable cells were gated for CD4 expression, then α-enolase expression was analysed in 
2000 CD4+ T cells.  
 
2.9  Real-time quantitative polymerase chain reaction (qPCR) 
Total RNA was used for cDNA synthesis (Quanta Bioscience cDNA synthesis kit). Real-time 
qPCR reactions were performed using cDNA (1µg) amplified in a standard 40-cycle SYBR® 
green real-time PCR reaction. Optimised, sequence-specific pre-validated primers for α-enolase 
and YWHAZ commercially available from Qiagen. YWHAZ was used for normalization. 
Relative fold difference in gene expression using the comparative CT method and statistical 
analysis were determined using the freely available Relative Expression Software Tool (REST 
2009, www.qiagen.com). 
 
2.10 Case-control cardiovascular disease cohort 
Ten consecutive patients (mean age 57.5 years) admitted to hospital with proven symptomatic 
coronary artery disease (CAD) were recruited with ten age-matched controls (mean age 60.5 
years). CAD was defined as the presence of one or more >50% stenosis on invasive coronary 
angiography, previous myocardial infarction (MI) and/or previous coronary revascularisation. 
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Within the hospital, healthy controls were recruited who were free from CAD (determined either 
by invasive coronary angiography or computed tomography [CT] coronary angiography and 
calcium scoring). Patients and controls were selected from City Hospital, Birmingham; and 
Sandwell General Hospital, West Bromwich, West Midlands, United Kingdom. 
Non-fasting peripheral venous blood samples were obtained from all of the study subjects with a 
21-gauge needle with minimal stasis into commercial tubes (Greiner Bio-One, Gloucestershire, 
United Kingdom) containing EDTA (for flow cytometric analysis). Samples were immediately 
fixed by adding 50µl blood into 500µl Optilyse and were then stored at -80oC until analysis. The 
study was performed in accordance with the Helsinki Declaration and approved by the 
Warwickshire Research Ethics Committee. All of the participants provided written, informed 
consent. 
 
2.10 Data analysis 
For comparison of values between young and older adult male groups, data from each group was 
checked for normality using the Kolmogorov-Smirnov test. A parametric independent samples t-
test was applied to the data and significance set at p < 0.05. Where necessary, data were log 
transformed. Data was analysed using SPSS statistical package version 20.0 for Windows (SPSS 
Inc, USA).  
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3 RESULTS 
 
3.1 Biotinylation of primary CD4+ T cells using Sulfo-NHS-SS Biotin reagent 
Using streptavidin SA-Alexa Fluor® 488 to visualize protein biotinylation on non-permeable and 
permeabilised T cells, the absence of signal on non-biotinylated CD4+ T cells treated with SA-
Alexa Fluor® 488 (Figure 1A) demonstrates that non-specific binding of SA-Alexa Fluor® 488 to 
T cell membranes is negligible. Sulfo-NHS-SS-Biotin labelled CD4+ T cells with SA-Alexa 
Fluor® 488 detection (Figure 1B) clearly show concentrated signal at the cell surface and absence 
of intracellular fluorescence indicating successful specific biotinylation of CD4+ T cell exofacial 
membrane proteins only. Permeabilized CD4+ T cells (Figure 1C) co-stained with Sulfo-NHS-
SS-Biotin and SA-Alexa Fluor® 488 show signal concentrated to the cell surface with minimal 
intracellular labelling. These data are in agreement with others (19) and infer that biotin-labelled 
CD4+ T cell proteins are at the exofacial cell surface of the plasma membrane.  
 
3.2 Purification of T cell plasma membrane proteins 
To confirm the specificity of the method described by Zhao and colleagues (20)  for recovery of 
plasma membrane but not cytosolic proteins, unlabelled cells from a Jurkat T cell line were 
incubated with streptavidin magnetic beads as a negative control. In these experiments no 
purified membrane or total protein was observed (data not shown). CD3, LDH and β-actin were 
used as markers of CD4+ T cell plasma membrane, cytosolic and cytoskeletal proteins 
respectively. As shown in Figure 2, after labelling exofacial proteins with biotin and purification 
using SA beads, CD4+ T cell plasma membrane proteins (e.g. CD3) are present in the PNS and 
SA-bead elution fraction but absent in the unbound fraction, whereas cytosolic proteins (e.g. 
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LDH) are present in the unbound fraction and absent in the SA-bead eluate. Cytoskeletal proteins 
(e.g. β-actin) are prominent in PNS and unbound fraction and greatly reduced in the eluate from 
SA beads. Together these data suggest that CD4+ T cell plasma membrane proteins are 
considerably separated from cytosolic and cytoskeletal contaminants using this technique. 
 
3.3 Age associated differences in human CD4+ T cell membrane proteome 
Healthy, non-smoking young (aged 18-35 years old) and older adult males (50-70 years old), 
were recruited for analysis of the human CD4+ T cell membrane proteome. Biochemical and 
anthropometric measurements confirmed that there were no significant differences observed 
between the two age groups for blood glucose, total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides or body mass index (Table 1).  
 
To assess age related differences between young and older adult males, CD4+ T cells were 
isolated from whole blood and membrane proteins extracted (described in experimental 
procedures section). Equal amounts of membrane proteins from young and older adult T cells 
were pooled into two age-defined groups and separated by 2DE (Figure 3). Differences to 
seventeen protein spots (ten spot densities increased and seven decreased in the older adult group 
when compared to the young adult group) were observed between young and older adults when 
criteria p < 0.05 and > 1.4 fold difference was applied. Four discrete and abundant spots which 
could be accurately excised, were analysed LC-MS/MS and protein identification was achieved 
for two spots as summarized in Table 2, including human α-enolase. 
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3.4 Validation of age related differences to CD4+ T cell membrane α-enolase and total 
enolase expression by flow cytometry and qPCR 
To validate the protein expression difference identified by 2DE analysis in whole blood, cell 
surface levels of α-enolase on CD4+ T cells between an independent group of young (n=8) and 
older (n =11) male adults was analysed by flow cytometry. There were no significant differences 
observed between the two age groups for blood glucose, total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides or body mass index and anthropometric data for these samples can be 
found in supplementary Table 1. Cell surface α-enolase was measured in the CD4+ T cell 
positive population (Figure 4A and 4B). A reduction in α-enolase on CD4+ T cells was 
demonstrated in the older compared to young male adult group (young group; 50.47 ± 13.26 Vs. 
older group; 38.98 ± 10.25 median fluorescence, p = 0.048, Figure 4C). The majority of CD4+ 
cells were α-enolase positive; 3.1% of CD4+ T cells from younger donors were α-enolase 
negative compared to 8.7% of CD4+ T cells from older donors. Total intra- and extra-cellular α-
enolase expression was also lower in a subset of six older (51-55 years) Vs younger (24-30 
years) subjects (p=0.03, Figure 4D). The decrease in cellular α-enolase expression in older adults 
was evident at the level of mRNA expression in older adults (p=0.029, Figure 4E).       
 
3.5 Cardiovascular associated differences in CD4+ T cell membrane α-enolase  
To investigate whether the loss in α-enolase on CD4+ T cells during ageing was related to health 
status and knowing that α-enolase is a plasminogen activator, we examined α-enolase expression 
in a case-control study of age-matched cardiovascular disease patients. There was no significant 
difference in age between case and control groups. A significant reduction (p=0.018) in α-
enolase on CD4+ T cells was demonstrated in cardiovascular disease patients (Figure 4F). 
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4 DISCUSSION 
To our knowledge this is the first study to demonstrate (a) primary CD4+ T cell membrane 
protein enrichment and isolation using a biotinylation reagent; (b) age-related differences in α-
enolase expression; and (c) cardiovascular disease-associated loss of α-enolase  at the CD4+ T 
cell membrane. Ageing and cardiovascular disease are associated with a decline in specific 
acquired immune response. Recent studies have indicated an immune-modulatory role for 
surface α-enolase (25).  Our findings suggest that further investigation of surface α-enolase 
function on specific subsets of CD4+ T cells during these conditions is merited to explore the 
potential contribution of α-enolase-dependent function immune decline.  
 
Using a previously described biotinylation enrichment method (19-20), we labelled lysine 
residues at the CD4+ T cell membrane with an impermeable biotinylation reagent which contains 
a disulphide bond. This disulphide bond becomes reduced in the intracellular environment, and 
thus on cell entry, no biotin is bound to lysine residues present on intracellular proteins. We 
provide evidence of a membrane protein fraction devoid of cytosolic protein contamination from 
primary CD4+ T cells by western blotting and confocal microscopy. The main purpose of this 
study was to identify age-related differences to the CD4+ T cell membrane proteome by 2DE. 
Protein expression profiles for CD4+ T cell membrane proteins were compared between young 
and older male adult groups. In total, seventeen protein spots were altered and from four protein 
spots which could be accurately excised, one protein, α-enolase which was identified by LC-
MS/MS, was decreased significantly in the older age group.  
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Intracellularly, α-enolase is known as a key glycolytic enzyme, responsible for catalysing the 
dehydration of 2-phosphoglycerate to phosphoenolpyruvate in the final steps of glycolysis. Aside 
from this well documented glycolytic activity, α-enolase has also more recently been implicated 
in many other biological and physiological processes (for a comprehensive review the reader is 
directed to Diaz-Ramos et al. (26)). α-Enolase has been detected on the surface of vascular 
endothelium (27) various cell types including monocytes, macrophages, B cells and T cells (28) 
and is recognized as a plasminogen receptor.  
 
Interaction between plasminogen and α-enolase at the cell surface has been shown to enhance its 
activation and concentrate plasmin-associated protease activity. A previous study undertaken by 
Aillaud and colleagues (29) in 20 young and 20 elderly individuals reported an age associated 
increase in the plasma level of plasminogen activator inhibitor-1, which inhibits plasmin 
production from plasminogen, with a likely increase in propensity for clotting; there is evidence 
that this is further increased in healthy centenarians compared to healthy elderly individuals (30).  
Another reported function for plasmin lies in the processing of integrins and therefore a decrease 
in localised plasminogen activation, following from loss of α-enolase on older adult T cells, may 
affect cell migration (31). 
 
The surface difference in α-enolase expression identified by 2DE approaches was verified in 
whole blood taken from volunteers of different ages by flow cytometry. The loss of enolase spot 
volume by 2DE may be in part due to a post-translational modification which altered enolase 
migration in the gel. However, we confirmed that there was significantly lower surface enolase 
expression in a second independent cohort of 8 young and 11 older adults. This proof of concept 
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was undertaken by analysis of individual subject CD4+ T cells using an antibody-based, flow 
cytometric method which did not require any pre-extraction of sample.  The distribution of α-
enolase was generally lower in older adults with a noticeable loss of CD4+ cells that expressed 
high levels of α-enolase. This may reflect an age-associated difference in specific CD4+ subset 
frequency (32) which merits future investigation for association with specific T cell subsets and 
effects on function.  While it could reflect a more generalised failure to traffic α-enolase to the 
surface in ageing T cells, this is less likely as our data suggests that α-enolase mRNA 
transcription is lower in T cells from older adults. Lower α-enolase expression with ageing 
implies a more refractory phenotype as T cells tend to tune down glycolysis in a resting state 
because higher energy flux with ATP production is not required for non-proliferating cells (33).  
The association of α-enolase with caveolar proteins, present in lipid rafts, regulates its 
subcellular localization (34). In ageing T cells fewer proteins are associated in rafts in the resting 
state but there is a failure of protein mobility within rafts during activation (35). This contrasts 
with senescent endothelial cells which showed significantly increased numbers of caveolae and 
associated proteins and promotion of anti-inflammatory pathways (36).   
 
The health-status of the young and older populations studied here were self-declared and based 
on lack of regular medication, however, the α-enolase expression was not always lower than the 
5th percentile of young adult expression. To investigate whether this is associated with vascular 
disease, we explored the expression of T cell surface α-enolase in cardiovascular disease patients 
compared to age-matched controls. In common with ageing, the presence of vascular disease in 
patients aged between 50 and 72 years was also associated with even lower surface α-enolase 
expression compared to age-matched healthy controls. There is increasing interest in the role of 
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T cells within the arterial wall and they have been implicated in the genesis of hypertension, 
vascular dysfunction, and cardiac fibrosis (37, 38). Indeed, Tregs were shown to ameliorate 
hypertension-driven vascular dysfunction through a paracrine-dependent mechanism raising a 
possible role for T cell-mediated therapeutics for vascular disease (14, 38).  
 
In addition to a difference in α-enolase expression, several other proteins were identified as 
altered between the young and older groups and excised for LC-MS/MS analysis. One protein 
spot appears to be two proteins of similar molecular weights and isoelectric point; both pro-
interleukin-16 and T-complex protein 1 subunit alpha were identified with high peptide cleavage 
and sequence coverage. A further two excised spots were unidentified. To improve speed of 
peptide extraction, recovery and coverage from excised membrane proteins we used an acid-
labile surfactant during tryptic digestion. However, the frequency of arginine and lysine residues 
is less in hydrophobic membrane proteins, resulting in fewer potential tryptic cleavage sites 
which may have contributed to our difficulty in identifying them. This was likely further 
compounded by labelling of lysine residues with biotin reagent for membrane protein enrichment 
of samples thereby reducing the available number of cleavage sites.  
 
Here, reduced α-enolase levels at the CD4+ T cell surface were observed in a healthy older 
compared to young male group and in a cardiovascular disease group compared to age-matched 
controls. Lower α-enolase levels in older adults may impact on plasminogen concentration at the 
T cell surface, plasminogen activation, plasmin proteolytic activity and plasmin-mediated 
intracellular signalling. Since lower surface α-enolase is evident during healthy ageing and is 
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lowered further in cardiovascular disease patients, its role in predisposition to vascular disease in 
older adults merits further investigation. 
 
5 CONCLUSION 
Using subcellular fractionation and gel-based proteomics, we have shown that cell surface 
expression of α-enolase is lower in older adults compared to younger people and in 
cardiovascular disease. This is the first study to identify an alteration in the expression of α-
enolase on the CD4+ T cell surface. Whether this impacts on the plasmin/plasminogen 
proteolytic system and T cell function remains to be investigated.  
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FIGURE LEGENDS 
Figure 1. Biotinylation of CD4+ T cell membrane proteins using Sulfo-NHS-SS-Biotin. 
CD4+ T cells were stained with SA-Alexafluor488 in the absence of Sulfo-NHS-SS-Biotin 
reagent (A). CD4+ T cells incubated with Sulfo-NHS-SS-Biotin reagent followed by no 
permeabilisation (B) or permeabilisation with Triton X-100 (C) prior to staining with SA-Alexa 
Fluor® 488. These data are representative of 3 independent experiments  with T cells from male 
subjects between 22 and 56 years where the scale bars shown are 5µm. 
 
Figure 2. Membrane protein purity. CD4+ T cell plasma membrane protein purity was 
assessed by measuring abundance of cytoplasmic protein (lactate dehydrogenase; LDH), plasma 
membrane protein (cluster of differentiation 3; CD3) and cytoplasmic associated protein (β-
actin) markers in post nuclear supernatant (PNS), unbound (UB) and eluted fractions (E) by 
western blot analysis (one gel representative of three independent experiments  with T cells from 
male subjects between 22 and 56 years). 
 
Figure 3. CD4+ T cell membrane protein separation by 2DE. Representative 2DE image of 
human CD4+ T cell membrane proteins (n=7, from two pools).  Membrane proteins were 
extracted and then separated on a pH 3-10 immobilised gradient and resolved on 8-16% SDS-
PAGE gels. Gels were visualised with Flamingo fluorescent total protein stain. Spot matching 
and data analysis was performed using Progenesis SameSpots software. Arrows indicate four 
discrete and abundant spots, altered between young and older groups, which were excised for 
protein identification by LC-MS/MS. Spot numbers correspond to spot identification numbers in 
Table 2.  
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Figure 4. Cell surface α-enolase levels are decreased on primary CD4+ T cells with age.  Cell 
surface α-enolase levels on CD4+ T cells were examined by flow cytometry. (A) Cells were 
separated by forward and side scatter and α-enolase levels measured on CD4+ T cells (white and 
filled peaks represent isotype control and anti-CD4 antibodies in the upper panel and isotype 
control and anti-α-enolase antibodies in the lower panel). (B) The comparative distribution of 
surface α-enolase on younger (red) versus older (blue) male CD4+ T cells relative to isotype 
control (black). (C) The age dependent difference in cell surface α-enolase levels on CD4+ T 
cells from 2DE analysis were validated in a younger (n = 8, mean age 27 years) and older (n =11, 
mean age 59 years) group. Values are expressed as median fluorescence and data are presented 
as a box plot. Percentiles are represented by the box (25th and 75th) and whisker (10th and 90th). 
* p = 0.048. (D) Total and surface α-enolase levels on CD4+ T cells in six younger and older 
adults were analysed by flow cytometry. The box represents 25th and 75th percentiles and the 
whisker, 10th and 90th. * p <0.05. (E) CD4+ T cell α-enolase mRNA expression relative to 
YWHAZ calculated using the ΔΔCt method. (F) Cell surface α-enolase levels are decreased on 
primary CD4+ T cells from patients with cardiovascular disease (CVD; mean age = 57.5 years) 
compared to healthy controls (Mean age 60.5 years). Values are expressed as median 
fluorescence and data are presented as a box plot with whiskers representing the 95% confidence 
intervals. * p = 0.018. 
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Table 1. Biochemical and anthropometric measurements in volunteers for 2DE study.  
 
 Young adult (n=10) Older adult (n=9) 
Age (years) 26 ± 2 56 ± 5* 
BMI 24.0 ± 3.3 25.0 ± 2.1 
Waist to hip ratio 0.90 ± 0.06 0.94 ± 0.05 
Glucose (mmol/L) 5.21 ± 0.44 5.30 ± 0.57 
Triglycerides (mmol/L) 1.11 ± 0.10 1.12 ± 0.06 
Cholesterol (mmol/L) 4.26 ± 1.19 4.93 ± 0.95 
LDL Cholesterol (mmol/L) 2.89 ± 1.18 3.43 ± 0.98 
HDL Cholesterol (mmol/L) 1.00 ± 0.21 1.11 ± 0.27 
 
Values expressed as mean ± SD; * difference relative to young (p < 0.001). 
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Table 2. Protein identification by LC-MS/MS 
 
Spot  
Number 
Fold 
Change 
(relative to 
younger; 
p<0.05) 
Protein 
Accession Number 
(NCBInr database) 
Δ Score 
 
Unique 
Peptides 
Identified 
Amino 
acid 
Coverage 
(%) 
1 ↑ 1.4 pro-IL 16 isoform 1 
T-complex protein 
1 subunit α 
27262655 
57863257 
660.96 
610.68 
 
17 
15 
46.28 
47.66 
       
3 ↓ 1.5 human Enolase-1 203282367 
 
470.94 
 
17 73.21 
       
 
 
 
 
